San Francisco Sentry Investment Group’s Idexx Laboratories IDXX Stock Holding History

San Francisco Sentry Investment Group’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-14	Closed	-$3K	–	762
2020 Q1	$3K	Hold	14	–	–	﹤0.01%	613
2019 Q4	$4K	Hold	14	–	–	﹤0.01%	660
2019 Q3	$4K	Hold	14	–	–	﹤0.01%	660
2019 Q2	$4K	Hold	14	–	–	﹤0.01%	660
2019 Q1	$3K	Hold	14	–	–	﹤0.01%	713
2018 Q4	$3K	Hold	14	–	–	﹤0.01%	708
2018 Q3	$3K	Buy	+14	New	+$3.4K	﹤0.01%	720
2018 Q2	–	Sell	-90	Closed	-$17K	–	794
2018 Q1	$17K	Hold	90	–	–	﹤0.01%	615
2017 Q4	$14K	Hold	90	–	–	﹤0.01%	629
2017 Q3	$14K	Buy	90 +30	+50%	+$4.74K	﹤0.01%	602
2017 Q2	$10K	Buy	+60	New	+$9.74K	﹤0.01%	530

Other funds holding IDXX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

San Francisco Sentry Investment Group's IDXX Position: Q2 2020 in Review

San Francisco Sentry Investment Group sold out of Idexx Laboratories (IDXX) in Q2 2020, closing a stake of 14 shares — an estimated $3K sold.

San Francisco Sentry Investment Group first reported a position in IDXX in Q2 2017 and held it in 11 quarters. The position peaked at $17K in Q1 2018. 802 funds tracked by Wall St. Rank hold IDXX as of Q2 2020.

San Francisco Sentry Investment Group reported no remaining Idexx Laboratories position as of Q2 2020 after selling out during the quarter.
San Francisco Sentry Investment Group sold 14 Idexx Laboratories shares in Q2 2020, an estimated $3K.
San Francisco Sentry Investment Group first reported a position in Idexx Laboratories in Q2 2017 and held it in 11 quarters.
San Francisco Sentry Investment Group's Idexx Laboratories position peaked at $17K in Q1 2018.
802 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2020.

Based on San Francisco Sentry Investment Group's 13F filing for Q2 2020, filed 17 Jul 2020.